Table 3.
Prognostic Role of Circulating Tumor Cells for Hepatocellular Carcinoma.
Study | Region | Year of Study | Type of Study | HCC Patient Number | Technique of Isolation | Key Findings |
---|---|---|---|---|---|---|
Chen et al. [99] | China | 2014–2020 | Retrospective analysis | 136 | CanPatrol, filtration and multiple mRNA ISH | CTC-WBC cluster ≥ 1/5 mL was associated with distant metastasis, tumor relapse and a shorter RFS |
Kelly et al. [87] | USA | 2011–2012 | Prospective study | 20 | CellSearch | CTCs ≥ 1 per 7.5 mL was associated with AFP ≥ 400 ng/mL and vascular invasion |
Liu et al. [88] | China | 2013 | Prospective study | 60 | CD45-ICAM-1+ | High frequency of CD45-ICAM-1+ cells (≥0.157%) was associated with a shorter DFS and OS. It is an independent risk factor for poor outcomes, including portal vein tumor thrombus and the presence of ascites |
Sun et al. [90] | China | 2010–2011 | Prospective study | 123 | CellSearch | CTCs ≥ 2 per 7.5 mL was found to be significantly associated with aggressive HCC phenotypes |
Schulze et al. [89] | Germany | 2013 | Prospective study | 59 | CellSearch | The presence of CTCs was associated with shorter OS advanced BCLC stage (stage C), microscopic vascular invasion, and elevated AFP ≥ 400 ng/mL |
Vona et al. [60] | France | 2004 | Prospective study | 44 | ISET method | The presence of CTCs was associated with diffuse tumors and portal tumor thrombosis. |
Yang et al. [101] | China | 2014–2017 | Prospective study | 105 | CanPatrol | M-CTC positivity was associated with AFP ≥ 400 ng/mL, tumor size ≥ 5 cm, the presence of multiple tumors, poorly differentiated tumors, incomplete tumor capsule, BCLC stage B or C, microvascular invasion and portal vein tumor thrombosis |
ISH: In Situ Hybridization; RFS: Relapse-Free Survival; TNM: Tumor (T), Nodes (N), and Metastases (M); OS: Overall Survival; DFS: Disease-Free Survival; BCLC: Barcelona Clinic Liver Cancer; ISET: Isolation by Size of Tumor cells.